Morgan Stanley has adjusted its ratings on several healthcare companies ahead of the upcoming reporting season. Ramsay Health ...

REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au operator's shares have delivered an average total return of 20.8% per annum.

Another blue chip ASX share I would happily build a portfolio around is REA Group. Its property platforms sit at the centre ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

The S&P 500 inched upward in New York trading, recovering from earlier losses as oil, gold, and silver prices increased amid ...

ResMed's (NYSE:RMD) stock up by 3.2% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be ...

Here are the steps to take if you want to build a significant passive income from ASX shares. The post How to make $24,000 in ...

ResMed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

AdvaMed CEO Scott Whitaker and new AdvaMed Chair Mick Farrell discussed the MDUFA VI negotiations, FDA performance, tariffs ...